| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
3e-07 |
| mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
4e-06 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
7e-06 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
1e-05 |
| mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
2e-05 |
| mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
4e-05 |
| mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
0.18 |
4e-05 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
5e-05 |
| mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
0.18 |
5e-05 |